Lipofit Extreme Fat Burner 2.0: a fat burner recalled for an antidepressant and an industrial poison
FDA published a company announcement of a nationwide voluntary recall of Lipofit Extreme Fat Burner 2.0 over undeclared fluoxetine and 2,4-dinitrophenol. Two undeclared substances, two very different kinds of failure.
Most of what we do here is arithmetic: find the dose behind the claim, compare it with the dose in the capsule, show the gap. That needs a label that tells you what is in the bottle.
Ana Salazar Modela Tu Cuerpo Inc., of Davie, Florida, announced a nationwide voluntary recall of Lipofit Extreme Fat Burner 2.0 on 27 August 2026, and FDA published the company announcement on 31 August. The recall covers Lot 25M12F, expiration date 09/2027, to the consumer level. Per the company announcement, FDA laboratory analysis found undeclared fluoxetine in the daytime (AM) tablets and undeclared 2,4-dinitrophenol (DNP) in the nighttime (PM) tablets. The product was sold in the United States directly to consumers online. The company says it has stopped selling it, quarantined remaining inventory under its control, and has no known reports of adverse events.
Two undeclared substances, two different problems
It is tempting to read “undeclared fluoxetine and DNP” as one offence twice over. It is not.
Fluoxetine is an active ingredient in an FDA-approved drug used for conditions including depression, bulimia and obsessive-compulsive disorder — a real medicine in the wrong container, normally prescribed with a diagnosis, a dose and a list of drugs it must not be taken alongside. None of that travels with a supplement bottle.
2,4-dinitrophenol is a different category of thing. The announcement describes it as a toxic substance used as a pesticide, dye, wood preservative and herbicide, illegally marketed as a weight-loss product and not approved by FDA for any use. There is no correct dose to compare against, because there is no approved use to derive one from.
FDA is carrying this product on two pages at once: the company recall announcement and a medication health fraud notification for hidden drug ingredients. The recall’s risk statement is long and specific: nausea, vomiting, sweating, dizziness and headaches; dangerous heart rhythm problems, rapid heart rate and cardiac arrest that can result in sudden death; seizures, abnormal bleeding and suicidal thoughts.
What a reader can actually do with this
Our usual advice — read the label, count the milligrams, ask what the trial dose was — is not available here. No amount of label arithmetic reaches a substance the label never names, which is the same lesson we drew from two ‘Esbelta’ products whose labels named none of the five substances found in them.
What is left is unglamorous. A recall notice is a lagging indicator; the tablets were sold long before the analysis. FDA does not approve dietary supplements before they go on sale, so “it was on the market” carries no assurance.
If you hold Lot 25M12F, the announcement says to stop using it immediately, keep it away from children and others, not pass it on, and contact the company for disposition instructions rather than mailing or discarding it first. Anyone who has taken it should speak to a doctor — that is a conversation for a clinician, not for us.